[144] Healthcare Realty Trust Incorporated SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Healthcare Realty Trust Incorporated (HR) reports a proposed sale of 15,000 shares of common stock through Charles Schwab with an aggregate market value of $262,050. The filing lists 351,606,597 shares outstanding and an approximate sale date of 09/04/2025 on the NYSE. The shares to be sold were acquired as equity compensation: 11,303 shares granted on 12/01/2019 and 3,697 shares granted on 12/01/2022, with payment/vesting events recorded on 12/11/2024. The filer reports no sales of the issuer's securities in the past three months and includes the standard signature representation regarding absence of undisclosed material information.

Positive

• Full compliance details provided: broker, share count, aggregate value, outstanding shares, and planned sale date are specified
• Acquisition history disclosed: the 15,000 shares were granted as equity compensation (12/01/2019 and 12/01/2022) with payment/vesting on 12/11/2024
• No recent sales: filer reports no sales of the issuer's securities in the past three months

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for an insider/recipient selling vested equity; not an earnings or corporate-action filing.

The filing documents a planned sale of 15,000 common shares valued at $262,050, executed through Charles Schwab and scheduled for 09/04/2025. Acquisition details show the shares originated from equity compensation grants in 2019 and 2022 with payment/vesting noted on 12/11/2024. The filer states no issuer securities were sold by the account in the prior three months. From a market perspective, this is a standard disclosure required to comply with Rule 144 and does not itself provide company performance information.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure showing sale of vested equity; procedural assurance included.

The notice fulfills procedural requirements by identifying the broker, share count, aggregate value, outstanding share base, and acquisition history tied to equity compensation. The signature statement affirms the filer is not aware of undisclosed material adverse information. This is a routine governance disclosure indicating the holder is following resale rules; it contains no governance changes or material corporate events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corp. 3000 Schwab Way Westlake TX 76262	15000	262050.00	351606597	09/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/01/2019	Grant	Issuer			11303	12/11/2024	Equity Compensation
Common	12/01/2022	Grant	Issuer			3697	12/11/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for Healthcare Realty Trust (HR) disclose?

The filing discloses a proposed sale of 15,000 common shares valued at $262,050 through Charles Schwab, with an approximate sale date of 09/04/2025.

How were the 15,000 HR shares acquired?

The shares were acquired as equity compensation: 11,303 shares from a 12/01/2019 grant and 3,697 shares from a 12/01/2022 grant, with payment/vesting noted on 12/11/2024.

Does the Form 144 indicate recent sales of HR stock by the filer?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Which broker will handle the sale of HR shares per the filing?

Charles Schwab Corp., 3000 Schwab Way, Westlake, TX, is named as the broker.

What outstanding share count and market value are reported in the HR Form 144?

The filing lists 351,606,597 shares outstanding and an aggregate market value for the proposed sale of $262,050.